RNO Insider Trading (Rhinomed)
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$175,016.57
Insider Selling (Last 12 Months): A$0.00
Rhinomed Share Price & Price History
Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET
Stock With Great Potential
From Wealthy Millionaire | Ad
Analyst says this stock could make quick strides with its unbelievable assets.
Learn more
Rhinomed Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 5/6/2022 | Eric Knight | Insider | Issued | 7,847 | A$0.19 | A$1,490.93 | | |
| 4/19/2022 | John McBain | Insider | Issued | 4,868,214 | A$0.19 | A$924,960.66 | | |
| 3/4/2022 | Ronald (Ron) Dewhurst | Insider | Buy | 100,000 | A$0.22 | A$22,000.00 | | |
| 2/3/2022 | Michael Johnson | Insider | Transfer | 2,700,000 | A$0.32 | A$861,300.00 | | |
| 12/20/2021 | Michael Johnson | Insider | Exercise | 3,000,000 | A$0.29 | A$861,000.00 | | |
| 7/2/2021 | John McBain | Insider | Buy | 487,921 | A$0.16 | A$77,091.52 | | |
| 6/24/2021 | John McBain | Insider | Buy | 506,167 | A$0.15 | A$75,925.05 | | |
| 12/23/2020 | Michael Johnson | Insider | Issued | 12,690,457 | A$0.17 | A$2,093,925.41 | | |
| 12/21/2020 | Ronald (Ron) Dewhurst | Insider | Buy | 1,000,000 | A$0.18 | A$180,000.00 | | |
| 12/14/2020 | Michael Johnson | Insider | Buy | 16,666 | A$0.18 | A$3,016.55 | | |
| 9/22/2020 | Ronald (Ron) Dewhurst | Insider | Buy | 250,000 | A$0.14 | A$33,750.00 | | |
| 6/26/2020 | Michael Johnson | Insider | Issued | 75,112 | A$0.08 | A$5,783.62 | | |
| 3/25/2020 | Ronald (Ron) Dewhurst | Insider | Buy | 300,000 | A$0.07 | A$21,000.00 | | |
| 1/24/2020 | Eric Knight | Insider | Issued | 1,000,000 | A$0.18 | A$180,000.00 | | |
How You Should Be Choosing Your Stocks
From Vantage Point | Ad
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades.
We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
Click here now to join and get access to our forecasting.
SEC Filings (Institutional Ownership Changes) for Rhinomed (ASX:RNO)
Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. It identifies, acquires, and commercializes nasal stent delivery technologies. The company's product portfolio includes Turbine for enhanced breathing in sports; Mute, an anti-snoring device; Pronto, a vapor inhaler to improve airflow and better sleep; and Rhinoswab that is used to collect a nasal swab. It also engages in developing programs in various markets, including sleep and sleep architecture, the impact of sleep and respiratory, function on cognitive issues, obstructive sleep apnea, pain, nausea, respiratory disease, and diagnostics and sensors; and offers a drug delivery platform for the delivery of cannabinoid formulations. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is based in Cremorne, Australia.
Read More on Rhinomed
Today's Range
Now: N/A
50 Day Range
MA: N/A
52 Week Range
Now: N/A
Volume
452,773 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Who are the company insiders with the largest holdings of Rhinomed?
